InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry
1 other identifier
observational
1,999
1 country
82
Brief Summary
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three or four leads (soft insulated wires) that are inserted through the veins to the heart. The purpose of this study is to monitor the long-term performance of the InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) systems for cardiac resynchronization therapy (CRT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2002
Longer than P75 for all trials
82 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2002
CompletedFirst Submitted
Initial submission to the registry
January 4, 2006
CompletedFirst Posted
Study publicly available on registry
January 9, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedResults Posted
Study results publicly available
August 5, 2013
CompletedAugust 5, 2013
July 1, 2013
9.1 years
January 4, 2006
April 13, 2012
July 1, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Death Rate and Cause Specific Death Rate During Three Years Post Implant.
Survival curves of overall mortality and cause specific mortality (due to progressive heart failure and sudden cardiac death) were created based on Kaplan-Meier estimates. Estimates went out to 36 month time point. Confidence intervals were calculated on a log-log scale. The Kaplan-Meier estimates are reported in the statistical analysis modules
36 month follow-up
Secondary Outcomes (4)
Left Ventricular (LV) Lead R-wave Amplitude
36 month follow-up
Left Ventricular (LV) Lead Impedance
36 months follow-up
Left Ventricular (LV) Lead Pacing Voltage Threshold
36 months follow-up
Subjects With Left Ventricular (LV) Lead Related Complications During Three Years Post-implant
36 months follow-up
Study Arms (1)
Cohort
Patients implanted with InSync Model 8040, InSync III Model 8042 , or Medtronic CRT-D system. A total of 1999 subjects were enrolled in the study. Of them, 1738 had successful post market implants of InSync Model 8040 (601 subjects), InSync III Model 8042 (512 subjects) and CRT-D devices (625 subjects). The rest 262 subjects came from two pre-market studies: the MIRACLE study added 141 subjects to InSync Model 8040, and the InSync III study added 121 subjects to the InSync III Model 8042. A total of 1014 subjects completed the study through 36 month follow up. Follow-up of 1000 subjects was required by the FDA to satisfy the conditions of approval.
Interventions
Eligibility Criteria
Patients indicated for use of a cardiac device
You may qualify if:
- Patients implanted with an InSync Model 8040 or InSync III Model 8042, a right ventricular lead, and a Medtronic market-released left ventricular lead as part of a system to deliver cardiac resynchronization therapy.
You may not qualify if:
- Patients with a history of a previously failed placement of a currently investigational Medtronic left ventricular lead within 30 days of enrollment in the InSync Registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (82)
Unknown Facility
Birmingham, Alabama, United States
Unknown Facility
Peoria, Arizona, United States
Unknown Facility
Fort Smith, Arkansas, United States
Unknown Facility
Little Rock, Arkansas, United States
Unknown Facility
Long Beach, California, United States
Unknown Facility
Napa, California, United States
Unknown Facility
Oxnard, California, United States
Unknown Facility
San Diego, California, United States
Unknown Facility
Yuba City, California, United States
Unknown Facility
Washington D.C., District of Columbia, United States
Unknown Facility
Gainesville, Florida, United States
Unknown Facility
Jacksonville, Florida, United States
Unknown Facility
Jupiter, Florida, United States
Unknown Facility
Melbourne, Florida, United States
Unknown Facility
Miami, Florida, United States
Unknown Facility
Orlando, Florida, United States
Unknown Facility
Tampa, Florida, United States
Unknown Facility
Atlanta, Georgia, United States
Unknown Facility
Rockford, Illinois, United States
Unknown Facility
Springfield, Illinois, United States
Unknown Facility
Indianapolis, Indiana, United States
Unknown Facility
Des Moines, Iowa, United States
Unknown Facility
Kansas City, Kansas, United States
Unknown Facility
Overland Park, Kansas, United States
Unknown Facility
Lexington, Kentucky, United States
Unknown Facility
Louisville, Kentucky, United States
Unknown Facility
Lake Charles, Louisiana, United States
Unknown Facility
Shreveport, Louisiana, United States
Unknown Facility
Baltimore, Maryland, United States
Unknown Facility
Salisbury, Maryland, United States
Unknown Facility
Silver Spring, Maryland, United States
Unknown Facility
Boston, Massachusetts, United States
Unknown Facility
Worchester, Massachusetts, United States
Unknown Facility
Detroit, Michigan, United States
Unknown Facility
Kalamazoo, Michigan, United States
Unknown Facility
Lansing, Michigan, United States
Unknown Facility
Marquette, Michigan, United States
Unknown Facility
Saginaw, Michigan, United States
Unknown Facility
Duluth, Minnesota, United States
Unknown Facility
Minneapolis, Minnesota, United States
Unknown Facility
Hattiesburg, Mississippi, United States
Unknown Facility
Tupelo, Mississippi, United States
Unknown Facility
Columbia, Missouri, United States
Unknown Facility
Kansas City, Missouri, United States
Unknown Facility
Saint Joseph, Missouri, United States
Unknown Facility
Springfield, Missouri, United States
Unknown Facility
St Louis, Missouri, United States
Unknown Facility
Billings, Montana, United States
Unknown Facility
Lincoln, Nebraska, United States
Unknown Facility
Newark, New Jersey, United States
Unknown Facility
Manhasset, New York, United States
Unknown Facility
New York, New York, United States
Unknown Facility
Rochester, New York, United States
Unknown Facility
Chapel Hill, North Carolina, United States
Unknown Facility
Charlotte, North Carolina, United States
Unknown Facility
High Pointe, North Carolina, United States
Unknown Facility
Raleigh, North Carolina, United States
Unknown Facility
Winston-Salem, North Carolina, United States
Unknown Facility
Cincinnati, Ohio, United States
Unknown Facility
Cleveland, Ohio, United States
Unknown Facility
Columbus, Ohio, United States
Unknown Facility
Mayfield Heights, Ohio, United States
Unknown Facility
Oklahoma City, Oklahoma, United States
Unknown Facility
Doylestown, Pennsylvania, United States
Unknown Facility
Erie, Pennsylvania, United States
Unknown Facility
Philadelphia, Pennsylvania, United States
Unknown Facility
York, Pennsylvania, United States
Unknown Facility
Providence, Rhode Island, United States
Unknown Facility
Greenville, South Carolina, United States
Unknown Facility
Spartanburg, South Carolina, United States
Unknown Facility
Nashville, Tennessee, United States
Unknown Facility
Dallas, Texas, United States
Unknown Facility
Fort Worth, Texas, United States
Unknown Facility
Houston, Texas, United States
Unknown Facility
Lubbock, Texas, United States
Unknown Facility
Sherman, Texas, United States
Unknown Facility
Salt Lake City, Utah, United States
Unknown Facility
Richmond, Virginia, United States
Unknown Facility
Virginia Beach, Virginia, United States
Unknown Facility
Seattle, Washington, United States
Unknown Facility
Morgantown, West Virginia, United States
Unknown Facility
Milwaukee, Wisconsin, United States
Related Publications (1)
Johnson WB, Abraham WT, Young JB, Wheelan K, Smith AL, Chang Y, Brinkman P; InSync Registry Investigators. Long-term performance of the attain model 4193 left ventricular lead. Pacing Clin Electrophysiol. 2009 Sep;32(9):1111-6. doi: 10.1111/j.1540-8159.2009.02451.x.
PMID: 19719485DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- InSync Registry Clinical Trial Leader
- Organization
- Medtronic, Inc.
Study Officials
- STUDY CHAIR
InSync Registry Study Leader
Medtronic
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2006
First Posted
January 9, 2006
Study Start
March 1, 2002
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
August 5, 2013
Results First Posted
August 5, 2013
Record last verified: 2013-07